These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6438742)

  • 21. Reorganization of noradrenergic neuronal systems following neonatal chemical and surgical injury.
    Kostrzewa RM
    Prog Brain Res; 1988; 73():405-23. PubMed ID: 3138742
    [No Abstract]   [Full Text] [Related]  

  • 22. The ontogeny of mu opiate tolerance and dependence in the rat: antinociceptive and biochemical studies.
    Windh RT; Little PJ; Kuhn CM
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1361-74. PubMed ID: 7791109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No evidence for involvement of endogenous opioid peptides in effects of clonidine on blood pressure, heart rate and plasma norepinephrine in anesthetized rats.
    Conway EL; Brown MJ; Dollery CT
    J Pharmacol Exp Ther; 1984 Jun; 229(3):803-8. PubMed ID: 6726658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphine attenuates the expression of sensitization to ethanol, but opioid antagonists do not.
    Abrahao KP; Quadros IM; Souza-Formigoni ML
    Neuroscience; 2008 Oct; 156(4):857-64. PubMed ID: 18804151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonidine suppression of noradrenergic hyperactivity during morphine withdrawal by clonidine: biochemical studies in rodents and primates.
    Roth RH; Elsworth JD; Redmond DE
    J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):42-6. PubMed ID: 6806253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potentiation of ethanol effects in cerebellum by activation of endogenous noradrenergic inputs.
    Wang Y; Freund RK; Palmer MR
    J Pharmacol Exp Ther; 1999 Jan; 288(1):211-20. PubMed ID: 9862773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of morphine but not fentanyl with cerebral alpha2-adrenoceptors in alpha2-adrenoceptor knockout mice.
    Höcker J; Böhm R; Meybohm P; Gruenewald M; Renner J; Ohnesorge H; Scholz J; Bein B
    J Pharm Pharmacol; 2009 Jul; 61(7):901-10. PubMed ID: 19589232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for an interrelationship between ventral noradrenergic bundle and CNS endorphins in the control of nociception in the rat.
    Millan MJ; Millan MH; Herz A
    Pain; 1982 Sep; 14(1):21-32. PubMed ID: 7145437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of an endogenous compound 1-methyl-1,2,3,4,-tetrahydroisoquinoline on morphine-induced analgesia, dependence and neurochemical changes in dopamine metabolism in rat brain structures.
    Wasik A; Romańska I; Antkiewicz-Michaluk L
    J Physiol Pharmacol; 2007 Jun; 58(2):235-52. PubMed ID: 17622694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of 6-hydroxydopamine and 6-hydroxydopa on development of behavior.
    Morgan DN; McLean JH; Kostrzewa RM
    Pharmacol Biochem Behav; 1979 Sep; 11(3):309-12. PubMed ID: 504311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opioid peptides inhibit noradrenergic transmission in the preoptic area to block LH secretion: evidence from neonatally androgenised rats.
    Dyer RG; Grossmann R; Mansfield S; Diez-Guerra FJ; Bicknell RJ; Hollingsworth S
    Brain Res Bull; 1988 Jun; 20(6):721-7. PubMed ID: 2842004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skin conductance activity after intraventricular administration of 6-hydroxydopa in rats.
    Yamamoto K; Hoshino T; Takahashi Y; Kaneko H; Ozawa N
    Biol Psychiatry; 1991 Feb; 29(4):365-75. PubMed ID: 1903660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of central noradrenergic system in thyrotropin-releasing hormone-induced behavioral excitement in 6-OHDOPA-treated, infant rats.
    Oki K; Nomura Y; Segawa T
    J Pharmacobiodyn; 1982 Sep; 5(9):716-9. PubMed ID: 6818336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antagonism by dopa of morphine analgesia. A hypothesis for morphine tolerance.
    Vander Wende C; Spoerlein MT
    Res Commun Chem Pathol Pharmacol; 1972 Jan; 3(1):37-45. PubMed ID: 5030707
    [No Abstract]   [Full Text] [Related]  

  • 35. Noradrenergic alterations in the brain stem of adult rats after a model perinatal insult.
    Buresová M; Benesová O; Tejkalová H
    Act Nerv Super (Praha); 1989 Oct; 31(3):229-31. PubMed ID: 2588988
    [No Abstract]   [Full Text] [Related]  

  • 36. Proceedings: Brain acetylcholine levels and nociceptive threshold in frogs after the administration of morphine, nalorphine and naloxone.
    Nistri A; Pepeu G
    J Physiol; 1974 Aug; 241(1):51P-52P. PubMed ID: 4547429
    [No Abstract]   [Full Text] [Related]  

  • 37. Loss of nerve cell bodies in caudal locus coeruleus following treatment of neonates with 6-hydroxydopa.
    Clark MB; King JC; Kostrzewa RM
    Neurosci Lett; 1979 Aug; 13(3):331-6. PubMed ID: 530483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential modification by opioid agents of acutely enhanced noradrenaline release in discrete brain regions.
    Kohno Y; Tanaka M; Hoaki Y; Ida Y; Nagasaki N
    Eur J Pharmacol; 1983 Sep; 92(3-4):265-8. PubMed ID: 6313396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Endogenous morphines--possible role in the pathogenesis of exogenous-constitutional obesity].
    Berestov LA
    Ter Arkh; 1983; 55(10):131-4. PubMed ID: 6316576
    [No Abstract]   [Full Text] [Related]  

  • 40. Different alterations in the development of the noradrenergic innervation of the cerebellum and the brain stem produced by neonatal 6-hydroxydopa.
    Zieher LM; Jaim-Etcheverry G
    Life Sci; 1975 Sep; 17(6):987-91. PubMed ID: 1195992
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.